Use and composition for treating myasthenia gravis and other myasthenic syndromes Grant US-11896582-B2 United States of America 13 Feb 2024
FORMULATIONS OF FOSAPREPITANT AND APREPITANT Application EP-4019023-A1 European Patent Office 29 Jun 2022
FORMULATIONS OF FOSAPREPITANT AND APREPITANT Application EP-3493815-A4 European Patent Office 28 Aug 2019
USE OF NON-PEPTIDE NK1 ANTAGONISTS IN A PREDETERMINED DOSE FOR THE TREATMENT OF CANCER Application WO-2015097322-A1 World Intellectual Property Organisation (WIPO) 02 Jul 2015